# The Role of Nitric Oxide in Cognition in Schizophrenia

> **NCT02906553** · NA · COMPLETED · sponsor: **King's College London** · enrollment: 19 (actual)

## Conditions studied

- Schizophrenia
- Psychotic Disorders

## Interventions

- **DRUG:** Glyceryl Trinitrate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02906553
- **Lead sponsor:** King's College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2019-04
- **Final completion:** 2019-04
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2019-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02906553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02906553, "The Role of Nitric Oxide in Cognition in Schizophrenia". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT02906553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*